This opportunity funds studies investigating how the innate immune system contributes to the initiation of Type 1 diabetes. It supports multidisciplinary research teams employing new approach methodologies to define environmental and genetic factors affecting disease onset. The goal is to improve early identification of individuals at risk and inform future prevention and therapeutic strategies.
Eligible applicants include a wide range of organizations such as state, county, city, and tribal governments, public and private educational institutions, nonprofits, for-profit organizations including small businesses, federal agencies, and non-U.S. entities. Specific eligibility details are provi
